These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 2902612

  • 1. [The effect of almitrine dimesylate on pulmonary hemodynamics in healthy subjects and in patients with chronic obstructive bronchitis].
    Ansquer JC.
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():409-10. PubMed ID: 2902612
    [No Abstract] [Full Text] [Related]

  • 2. [Almitrine dimesylate (vectarion)--the first representative of a new group of "synergetic" drugs--and its use in pulmonary pathology].
    Mihalţan F.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1987 Jun; 36(3):209-19. PubMed ID: 2894713
    [No Abstract] [Full Text] [Related]

  • 3. [Effect of almitrine, a chemoreceptor stimulator, on nocturnal hypercapnia and pulmonary artery pressure during O2 respiration in chronic obstructive lung disease].
    Rühle KH, Kempf P, Mössinger B, Klein G, Costabel U, Würtemberger G, Matthys H.
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():411-4. PubMed ID: 2902613
    [No Abstract] [Full Text] [Related]

  • 4. Almitrine as a long term treatment for chronic obstructive pulmonary disease.
    Kauffmann F.
    Bull Eur Physiopathol Respir; 1987 Jun; 23(6):667. PubMed ID: 2899444
    [No Abstract] [Full Text] [Related]

  • 5. Undetermined utility of almitrine.
    Patz D.
    Chest; 1987 May; 91(5):794. PubMed ID: 2882957
    [No Abstract] [Full Text] [Related]

  • 6. [Influence of almitrine dimesylate on gas exchange. Preliminary results in patients with chronic obstructive bronchopneumopathies under artificial ventilation].
    Castaing Y, Manier G, Guenard H.
    Presse Med; 1984 Oct 04; 13(34):2078-82. PubMed ID: 6149535
    [Abstract] [Full Text] [Related]

  • 7. [Almitrine dimesylate: ventilatory or vascular action].
    Préfaut C, Bourgouin-Karaouni D.
    Rev Med Interne; 1985 Oct 04; 6 Spec No():3-7. PubMed ID: 3914681
    [No Abstract] [Full Text] [Related]

  • 8. [Lung function and blood gas analysis studies in patients with COPD and respiratory insufficiency receiving almitrine medication with special reference to its clinical aspects].
    Hillebrand M, Siemon G.
    Prax Klin Pneumol; 1988 Jun 04; 42 Suppl 1():391-3. PubMed ID: 2902610
    [No Abstract] [Full Text] [Related]

  • 9. Improvement in ventilation-perfusion matching by almitrine in COPD.
    Mélot C, Naeije R, Rothschild T, Mertens P, Mols P, Hallemans R.
    Chest; 1983 Mar 04; 83(3):528-33. PubMed ID: 6130897
    [Abstract] [Full Text] [Related]

  • 10. [Peripheral neuropathy in chronic bronchopathy. A study of 128 patients].
    Lerebours G, Nouvet G, Senant J, Moore N, Arnaud F.
    Prax Klin Pneumol; 1988 Jun 04; 42 Suppl 1():400-2. PubMed ID: 2902611
    [No Abstract] [Full Text] [Related]

  • 11. [Originality of the mode of action of almitrine dimesylate].
    Tellier P.
    Presse Med; 1984 Oct 04; 13(34):2083-9. PubMed ID: 6149536
    [Abstract] [Full Text] [Related]

  • 12. [Pulmonary hemodynamic effects of intravenous almitrine in patients with chronic bronchitis and respiratory insufficiency].
    Weitzenblum E, Ehrhart M, Schneider JC, Hirth C, Roegel E.
    Bull Eur Physiopathol Respir; 1982 Oct 04; 18(5):765-73. PubMed ID: 6152773
    [Abstract] [Full Text] [Related]

  • 13. [Almitrine bismesylate. A peripheral chemoreceptor agonist].
    Nielsen SP.
    Ugeskr Laeger; 1988 Nov 14; 150(46):2797-800. PubMed ID: 2905090
    [No Abstract] [Full Text] [Related]

  • 14. [Effects of oral almitrine on the distribution of VA/Q ratio in chronic obstructive lung diseases (author's transl)].
    Castaing Y, Manier G, Varène N, Guénard H.
    Bull Eur Physiopathol Respir; 1981 Nov 14; 17(6):917-32. PubMed ID: 7032629
    [Abstract] [Full Text] [Related]

  • 15. [Experimental and clinical bases for the respiratory action of almitrine].
    Lecomte J, Lagneaux D.
    Rev Med Liege; 1986 May 15; 41(10):451-5. PubMed ID: 2874604
    [No Abstract] [Full Text] [Related]

  • 16. Effect of almitrine bismesylate on pulmonary vasoreactivity to hypoxia in chronic obstructive pulmonary disease.
    Saadjian AY, Philip-Jöel FF, Barret A, Levy S, Arnaud AG.
    Eur Respir J; 1994 May 15; 7(5):862-8. PubMed ID: 8050541
    [Abstract] [Full Text] [Related]

  • 17. [Pulmonary hemodynamic monitoring in chronic respiratory insufficiency treated with almitrine bismesilate for 4 months in a double-blind study].
    Bourgouin-Karaouni D, Ramonatxo M, Michel FB, Macabies J, Prefaut C.
    Rev Mal Respir; 1984 May 15; 1(4):245-50. PubMed ID: 6505362
    [Abstract] [Full Text] [Related]

  • 18. [Analysis and criticism of hemodynamic investigations during respiratory analeptic dispensing (author's transl)].
    Daijardin JB, Pourriat JL, Hoang P, Lapandry C, Cupa M.
    Anesth Analg (Paris); 1980 May 15; 37(9-10):557-60. PubMed ID: 6110386
    [Abstract] [Full Text] [Related]

  • 19. [Should arterial gas values be improved in patients with chronic bronchitic respiratory insufficiency? Value of almitrine dimesylate].
    Prefaut C.
    Presse Med; 1984 Oct 04; 13(34):2090-3. PubMed ID: 6149537
    [Abstract] [Full Text] [Related]

  • 20. Clinical pharmacology of almitrine bismesylate.
    Pariente R.
    Eur J Respir Dis Suppl; 1983 Oct 04; 126():271-4. PubMed ID: 6586441
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.